Naijian Li

Naijian Li

Auto-generated profile, based on publicly available information

Naijian Li

State Key Laboratory of Respiratory Disease , National Clinical Research Center for Respiratory Disease , Guangzhou Institute of Respiratory Health , Department of Allergy and Clinical Immunology , The First Affiliated Hospital of Guangzhou Medical University , Guangzhou , Guangdong , China , gzhmc.edu.cn

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in Respiratory Medicine
Verified
Journal Article
Open access
NLNaijian Li
Naijian Li
RQRihuang Qiu
Rihuang Qiu
ZYZhaowei Yang
Zhaowei Yang
JLJing Li
Jing Li
KCKian Fan Chung
Kian Fan Chung
QZQingling Zhang
Qingling Zhang
Altered composition of airway microbiota has been reported in subjects suffering from asthma but its relation to eosinophilic phenotype is unclear. To examine the relationship between sputum microbiota, asthma severity and inflammatory type in asthmatic subjects from Guangzhou, China. Induced sputum samples were obtained from 49 non-smoking asthma patients, 25 severe and 24 non-severe, and 15 healthy subjects. Total DNA was amplified using primers specific for the V3-V5 hypervariable region of bacterial 16s rRNA and sequenced using the 454 GS FLX sequencer. Sequences were assigned to bacterial taxa by comparing them with 16s rRNA sequences in the Ribosomal Database Project. Sputum eosinophil counts were higher and FEV1 (% predicted) was lower in severe compared to non-severe asthmatics. There were no significant differences in operational taxonomic unit (OTU) numbers at the phylum level and in diversity scores between non-severe asthmatics and severe asthmatics, and healthy subjects. At the family level, Porphyromonadaceae was most abundant in healthy subjects whereas Pseudomonadaceae and Enterobacteriaceae were higher in severe asthmatics compared to non-severe asthmatics (p < 0.05). Actinomycetaceae was particularly abundant in eosinophilic asthma patients compared to non-eosinophilic asthma (p = 0.011). Bacteroidaceae was positively correlated with FEV1 in all subjects (r = 0.335, p < 0.01), whereas body mass index was negatively associated with the number of species observed (r = -0.3, p < 0.05). Principal component analysis confirmed the positive association of Actinomycetaceae and Enterobacteriaceae abundance with eosinophilic asthma. Patients with asthma have an altered airway microbiota, with specific bacteria associated with severe asthma and the eosinophilic inflammatory phenotype.

1 November 2018 in The Journal of Allergy and Clinical Immunology: In Practice
Verified
Journal Article
Closed access
RQRihuang Qiu
Rihuang Qiu
JXJiaxing Xie
Jiaxing Xie
KCKian Chung
Kian Chung
NLNaijian Li
Naijian Li
ZYZhaowei Yang
Zhaowei Yang
QZQing ling Zhang
Qing ling Zhang

1 January 2026 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
PZPing-An Zhang
Ping-An Zhang
JWJie-Lin Wang
Jie-Lin Wang
SFShi-Yan Fu
Shi-Yan Fu
HLHua-Lian Luo
Hua-Lian Luo
NLNai-Jian Li
Nai-Jian Li
JLJing Li
Jing Li
Background: Allergic diseases, including allergic asthma (AA), allergic rhinitis (AR), atopic dermatitis (AD), and allergic conjunctivitis (AC), often coexist. However, the specific inflammatory mediators driving their shared mechanisms remain unclear. This study explored causal relationships and identified multiomic mediators among allergic diseases using Mendelian randomization (MR). Methods: Large‐scale GWAS datasets from FinnGen and UK Biobank were analyzed. Linkage disequilibrium score regression (LDSC) and MR–robust adjusted profile scoring (MR‐RAPS) assessed genetic correlations and causal links. Crucially, multivariable MR (MVMR) adjusted for classical type 2 inflammatory factors to isolate independent effects. A two‐step MR framework evaluated the mediating roles of immune cells, metabolites, gut microbiota, and serum proteins. Results: Six disease pairs (AA–AR, AA–AD, AR–AA, AR–AD, AD–AA, and AD–AR) showed robust causal relationships independent of type 2 inflammation markers. Mediation analyses identified key inflammatory mediators, including immune cell subsets (e.g., CD45 on granulocytes), plasma metabolites (e.g., pentose acid), gut microbiota (e.g., Bacteroides intestinalis ), and notably, serum proteins such as ABHD12 and SEZ6L2. Pathway analyses highlighted cytokine–cytokine receptor interactions and lipid metabolism. Conclusions: This study maps a comprehensive causal network of allergic multimorbidity. We identified novel serum proteins and metabolic mediators beyond the classical type 2 inflammation axis, offering potential therapeutic targets for disrupting the inflammatory crosstalk between allergic diseases.